Pletal and Famvir drug interactions - from FDA reports

Summary

Drug interactions are reported only by a few people who take Pletal and Famvir together. This review analyzes the effectiveness and drug interactions between Pletal and Famvir. It is created by eHealthMe based on reports of 4 people who take the same drugs from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on cilostazol and famciclovir (the active ingredients of Pletal and Famvir, respectively), and Pletal and Famvir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Pletal?

Pletal has active ingredients of cilostazol. It is often used in blockage of leg arteries. (latest outcomes from Pletal 6,062 users)

What is Famvir?

Famvir has active ingredients of famciclovir. It is often used in herpes labialis (oral herpes simplex). (latest outcomes from Famvir 2,721 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 24, 2019

4 people who take Pletal, Famvir are studied.


Number of reports submitted per year:

Pletal and Famvir drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Abasia (inability to walk)
  2. Altered state of consciousness (altered state of mind)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Dysarthria (speech disorder)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. General physical health deterioration (weak health status)
  7. Pyrexia (fever)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Speech disorder
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Abdominal discomfort
  2. Pruritus (severe itching of the skin)
  3. Rash
  4. Rash erythematous (redness of the skin)
  5. Rash macular (small, flat red spots)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Rib fracture
  8. Sick sinus syndrome (a collection of heart rhythm disorders)
  9. Sinusitis (inflammation of sinus)
  10. Skeletal injury (bone and supporting muscle injury)

Most common drug interactions by gender *:

female:
  1. Abdominal tenderness
  2. Abscess (pus)
  3. Actinic keratosis (skin disease due to sun exposure)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia (lack of blood)
  6. Anxiety
  7. Arterial disorder
  8. Arterial insufficiency (lack of enough blood flow through the arteries)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Arthralgia (joint pain)
male:
  1. Abasia (inability to walk)
  2. Altered state of consciousness (altered state of mind)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Dysarthria (speech disorder)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. General physical health deterioration (weak health status)
  7. Pyrexia (fever)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Speech disorder

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:
  1. Dysarthria (speech disorder)
  2. Abasia (inability to walk)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Arterial disorder
  5. Arterial insufficiency (lack of enough blood flow through the arteries)
  6. Arteriosclerosis (thickening and hardening of arteries)
  7. Arthralgia (joint pain)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Arthropathy
  10. Articular calcification

* Approximation only. Some reports may have incomplete information.


Do you take Pletal and Famvir?


You are not alone, use our "Ginger Health" app to:

  • connect with people like you who take Pletal and Famvir
  • use your healthcare experience to help people like you, and be rewarded



Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Pletal and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Famvir and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Pletal and Famvir
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Pletal and Famvir



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.